Anavex Life Sciences (AVXL) Tax Rate (2016 - 2025)

Anavex Life Sciences (AVXL) posted Tax Rate of 0.0% for Q4 2025, down 100.13% sequentially from 0.55% in Q2 2024.

Anavex Life Sciences (AVXL) Tax Rate (2016 - 2025) Analysis & Trends

Anavex Life Sciences has reported Tax Rate for 10 years, with the latest figure at 0.0% in Q4 2025.

Quarterly Tax Rate changed N/A year-over-year to 0.0% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (changed N/A YoY) and the FY2023 annual result came in at 0.01%, up 74.0% from the prior year.
Tax Rate declined to 0.0% in Q4 2025 per AVXL's latest filing, from 0.55% in the prior quarter.
Over five years, Tax Rate peaked at 0.63% in Q3 2023 and troughed at 1.49% in Q3 2022.
A 5-year average of 0.41% and a median of 0.36% in 2023 frame the typical range for Tax Rate.
The widest YoY moves for Tax Rate: up 212 bps in 2023, down 115 bps in 2023.
Over 5 years, Tax Rate stood at 0.28% in 2021, then soared by 156 bps to 0.15% in 2022, then sank by 747 bps to 1.0% in 2023, then surged by 155 bps to 0.55% in 2024, then sank by 100 bps to 0.0% in 2025.
According to Business Quant data, Tax Rate over the past three periods registered 0.0%, 0.55%, and 1.01% for Q4 2025, Q2 2024, and Q1 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	15.11%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.91%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	24.15%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-9.47%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	7.49%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-16.71%
10	Anavex Life Sciences	298.40 Mn	166.65 Mn	-	0.00%

Download Data